A comparative overview of COVID-19, MERS and SARS: Review article
2020/07/26 by Jie Liu, Wanli Xie, Yanting Wang +4 · 1 voice · 1 citation
Medicine · Psychology · #COVID-19 Clinical Research Studies #SARS-CoV-2 and COVID-19 Research #COVID-19 and Mental Health
paper · pdf · doi:10.1016/j.ijsu.2020.07.032
openalex publication_date 2020/07/26 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04
Abstract
Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), a third, highly pathogenic coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appearing at end of 2019 led to a pandemic, increased panic and attracted global attention. This review analyzes the epidemiology, etiology, clinical characteristics, treatment and sequelae of the severe acute respiratory syndrome (SARS), the Middle East respiratory syndrome (MERS) and the 2019 novel coronavirus disease (COVID-19) to help provide direction for further studies that can help understand COVID-19.
Citations
- Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- Structural basis of receptor recognition by SARS-CoV-2
- Virological assessment of hospitalized patients with COVID-2019
- The COVID-19 vaccine development landscape
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Cited by
Discussions
- Liu, Jie, Wanli Xie, Yanting Wang, Yue Xiong, Shiqiang Chen, Jingjing Han, and Qingping Wu. ‘A Comparative Overview of COVID-19, MERS and SARS: Review Article’. International Journal of Surgery 81 (Se [bsky, 0 points, 1 comments]
Related